Floatz logo

Acetylsalicylic Acid

Endovascular Thrombectomy

Sunnybrook Health Sciences CentreN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Endovascular Thrombectomy cohort.

Asset / SponsorPhaseRating
LABETALOL
Hamilton Health Sciences Corporation
Phase 2B
Hydralazine
Hamilton Health Sciences Corporation
Phase 2B
Tenecteplase
Yi Yang
Phase 2/3B
Compound Edaravone
Hui-Sheng Chen
Phase 2B
Arestin
Xiang Luo
Phase 2/3B

View all 10 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →